Skip to main content
. 2023 Feb 13;13:1027254. doi: 10.3389/fonc.2023.1027254

Figure 3.

Figure 3

PEG-PLGA-PEG chemical structure, preparation of 188Re-ECD-Lipiodol/hydrogel, and hepatoma animal model treatment. (A) Chemical structure of PEG-PLGA-PEG. (B) Optical images of 188Re-ECD-Lipiodol/hydrogel, prepared by mixing PEG-PLGA-PEG (30% w/w) and 188Re-ECDLipiodol in a 1:1 ratio. (C) 188Re-ECD-Lipiodol/hydrogel was administered to N1-S1 hepatoma-bearing rats via intratumoral injection (60).